Vivitrol FDA Approved for Opiate Relapse Prevention
Tarzana Treatment Centers in Los Angeles is thrilled at the news that the Federal Drug Administration (FDA) has approved Vivitrol for use in opioid addiction treatment. The evidence was clear to us that Vivitrol reduced opiate cravings, but the FDA went one step further in approving it for the “prevention of relapse to opioid dependence.” This means that we can finally say what we’ve also known for a long time; Vivitrol prevents relapse.
Tarzana Treatment Centers offers Vivitrol for alcohol treatment and opiate treatment as part of our Medication Assisted Treatment (MAT) program. It is a Naltrexone injection taken monthly that reduces alcohol cravings and opiate cravings. This allows individuals in recovery to focus on addiction treatment, and offers a better chance at long-term recovery. For more information about the FDA approval and Vivitrol, click the link below for the press release by Vivitrol manufacturer, Alkermes.
Tarzana Treatment Centers in Los Angeles provides a full array of health care services including adult and youthalcohol and drug treatment. We specialize in treatment for mental health and substance use disorders, and have two primary medical care clinics in the San Fernando Valley and Antelope Valley. If you or a loved one needs help with alcohol dependence, drug addiction, or co-occurring mental health disorders, please call us now at 888-777-8565 or contact us here.
Southern California Locations for Alcohol and Drug Treatment
Tarzana Treatment Centers has locations all over Southern California in Los Angeles County. Other than our central location in Tarzana, we have facilities in Lancaster in the Antelope Valley, Long Beach, and in Northridge and Reseda in the San Fernando Valley.